中國心連心化肥(01866.HK)附屬擬就集團產品進行期貨交易
格隆匯1月6日丨中國心連心化肥(01866.HK)發佈公告,公司附屬公司河南心連心化學工業集團股份有限公司已經被鄭州商品交易所指定為尿素期貨交割廠庫之一,負責於尿素期貨合同交割時交付尿素,同時河南心連心的尿素產品為免檢交割品牌。為了降低集團產品市場價格波動的風險,河南心連心擬常規化地就集團產品(包括尿素和甲醇)進行期貨交易。
鑑於期貨交易有虧損風險,為了降低前述風險,集團已採納期貨投資管理制度以規範其投資。根據該制度,河南心連心僅可於國內獲合法授權的期貨交易市場內(而非場外),利用自有資金進行相關產品的期貨交易。由於上述業務只能以對衝集團的風險而非投機和套利的目的進行,期貨交易的持倉量不得超過相關產品的庫存或倉單數量,相應期貨頭寸的持有時間原則上不得超出相關現貨合同規定的或該合同實際執行的時間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.